HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P Canhão Selected Research
P Canhão Research Topics
Disease
3
Seizures (Absence Seizure)
10/2017 - 01/2017
3
Stroke (Strokes)
01/2017 - 10/2013
2
Inflammation (Inflammations)
01/2021 - 01/2014
2
Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2014 - 01/2004
1
Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1
Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2017
1
Epilepsia Partialis Continua
01/2017
1
Leukocytosis (Pleocytosis)
01/2014
1
Tuberculosis (Tuberculoses)
01/2014
1
Vasculitis (Vasculitides)
01/2014
1
Central Nervous System Vasculitis
01/2014
1
Intracranial Hypertension
01/2014
1
Ischemic Stroke
10/2013
1
Embolic Stroke
10/2013
1
Disease Progression
01/2004
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 10/2013
2
Anticoagulants
IBA
01/2014 - 01/2004
1
Anticonvulsants (Antiepileptic Drugs)
IBA
10/2017
1
erucylphosphocholine
IBA
01/2017
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
01/2017
1
Proteins (Proteins, Gene)
FDA Link
01/2014
1
Ribavirin (Virazole)
FDA Link
Generic
01/2014
1
Gadolinium
IBA
01/2014
1
Cryoglobulins
IBA
01/2014
1
Transaminases (Aminotransferases)
IBA
01/2014
1
Oligoclonal Bands
IBA
01/2014
1
Interferons
IBA
01/2014
1
pro-brain natriuretic peptide (1-76)
IBA
10/2013
1
Brain Natriuretic Peptide (Natrecor)
FDA Link
10/2013
1
Fibrinolytic Agents (Antithrombotic Agents)
IBA
01/2004
Therapy/Procedure
2
Therapeutics
01/2014 - 01/2004
1
Thrombectomy
10/2017
1
Ventriculoperitoneal Shunt
01/2014
1
Thrombolytic Therapy
01/2004